Navigation Links
Clinical studies in the pipeline: the therapies of tomorrow in trials today
Date:10/23/2007

conclusion concerning the efficacy of interleukin-21 in combination with sorafenib compared to use of sorafenib alone, he said. To date, most adverse events seen have been mild and moderate, Dr. Thompson adds.

Because the two drugs work in very different ways and both have low toxicity profiles, the researchers predicted they would have additive or even synergistic effects when used in combination. Pre-clinical studies in mice showed that, indeed, the two together work better than either alone, Dr. Thompson says.

Sorafenib, a tyrosine kinase inhibitor approved for use in December 2005 under the trademark Nexavar, blocks enzymes in cancer cells that promote tumor growth and also blocks blood vessel growth in tumors, thereby depriving the tumor of nutrients and oxygen. Although sorafenib does not typically cause a large shrinkage of the tumor, it can prevent the tumor from growing further, and has been shown to delay the progression, or growth, of kidney cancer, Dr. Thompson said.

Recombinant IL-21 activates the immune system to kill cancer cells. Immune therapies have been shown to work in kidney cancer in the past, but those previously available were very toxic and poorly tolerated by most patients. Recombinant IL-21 is well tolerated by most patients, Dr. Thompson said. In our clinical trial of recombinant IL-21 by itself, we saw encouraging responses in patients with kidney cancer.

Therefore, treatment with sorafenib may make the cancer more susceptible to a killing response by an activated immune system, he says. We are looking forward to the Phase II portion of the study to better evaluate the overall safety profile and anti-tumor activity, Dr. Thompson said.

Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials: Number C192

Preclinical studies suggest that a small molecule inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) may be an effective anti
'/>"/>

Contact: Greg Lester
greg.lester@aacr.org
267-646-0554
American Association for Cancer Research
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Private equity consultant and international research ... that its dental stem cell biobank project, Provia ... April, 2015 –and posted yet another exciting record. This ... and represents a significant 54% increase over last April ... is conducted via the Store-A-Tooth brand. The company has ...
(Date:5/5/2015)... 2015 NCPDP announced today that ... program establishes a three-year commitment of strategic support for ... Elite Partners. “AmerisourceBergen has supported our multi-stakeholder forum over ... “and this is a wonderful continuation and expansion of ... trace AmerisourceBergen back to our very first Board of ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 Leveraging ... Clinic in Greece, an experienced team of fertility ... of infertility for patients around the globe. , “We’re ... VisitandCare.com. Greece unquestionably remains a global leader in reproductive ... and hard-working fertility specialists in the world who play ...
(Date:5/5/2015)... New York, New York (PRWEB) May 05, ... treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on ... cardiovascular complications due to their use of ... forward in the federal multidistrict litigation underway ... Illinois. According to court documents dated May ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Baptist Medical ... Commission on Cancer (CoC) of the American College of ... program must meet more than 30 Commission on Cancer ... a survey process, and maintain levels of excellence in ... When patients choose to seek care locally at a ...
Breaking Medicine News(10 mins):Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4
... ... ... ... ...
... ... ... , ... , , , , ...
... ... ... , ... , , ...
... 2010 winners of the Young Investigator Award. This ... individuals within 5 years of receiving doctoral degrees who ... Biology 2010 meeting in Anaheim in April 2010. ... by a committee on the basis of originality and importance ...
... ... of the Center for Quality Growth and Regional Development at Georgia Institute of Technology, ... Forum: Livability and Sustainable Communities – Taking Action for a Clean Energy Future. ... Atlanta, Ga. (PRWEB) ...
... ... ... ... ...
Cached Medicine News:Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 2Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 3Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 4Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 5Health News:FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs 6Health News:Consumer Alert: Denture Cream Maker Warns Doctors of Product Dangers 2Health News:Consumer Alert: Denture Cream Maker Warns Doctors of Product Dangers 3Health News:Consumer Alert: Denture Cream Maker Warns Doctors of Product Dangers 4Health News:89 Women Celebrate Mardi Gras with Mammograms 2Health News:89 Women Celebrate Mardi Gras with Mammograms 3Health News:SEBM Young Investigator Awards for 2010 2Health News:Dr. Catherine Ross to Participate Today in White House Clean Energy Economy Forum 2Health News:Dr. Catherine Ross to Participate Today in White House Clean Energy Economy Forum 3Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 2Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 3Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 4Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 5Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 6Health News:Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies 7
(Date:5/5/2015)... May 5, 2015  The preclinical contract research organization ... testing of drugs and safety testing of medical devices, ... of Preclinical Studies, presented at this week,s annual meeting ... (ARVO) in Denver, CO. The ... of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) ...
(Date:5/5/2015)... and NIJMEGEN, the Netherlands ... medical device company developing lower esophageal sphincter (LES) ... long-term, 3-year, positive safety and efficacy results. The ... of both heartburn and regurgitation and the "gold-standard" ... test) with near-complete elimination of dependence on daily ...
(Date:5/5/2015)... and Markets ( http://www.researchandmarkets.com/research/9pthtm/home_healthcare ) has announced ... - Forecast to 2020" report to their offering. ... reach more than $300+ billion growing at a CAGR ... market is expected to grow at a faster rate ... gaining a tremendous attention over hospitals for the sophistication, ...
Breaking Medicine Technology:Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2
... More Effective Monitor Than, Hemoglobin A1C of Exenatide, Sitagliptin, ... ... 7 GlycoMark, Inc. announced today,results from the ongoing ... a better reflection of glucose, particularly after-meal,glucose levels, than ...
... June 6 , - "ADVANCE Results go ... world,s largest ever study of diabetes treatments,show that ... and other drugs as required, protects patients against ... reduces,the risk of kidney disease by one-fifth. Presented ...
Cached Medicine Technology:DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes 2DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes 3The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications 2
... MB Grade PRODUCT SPECIFICATIONS Form: Granular, free flowing powder ... 0.12 Gel Point (3%): less than or equal ... equal to 76C Gel Strength (3%): greater than or ... greater than or equal to 1000 gm/cm 2 ...
... chloride (Cl) ≤ 500 mg/kg sulfate (SO 4 ) ... Cd ≤ 5 mg/kg Co ≤ 5 mg/kg Cr ... 10 mg/kg K ≤ 50 mg/kg Mg ≤ 50 ... Ni ≤ 5 mg/kg Pb ≤ 5 mg/kg Zn ...
... Application: Forms strong flexible ... ( ID clarifier: mixture of ... 3:1 Solubility: water 10 mg/mL, ... grade: for molecular biology MP: ...
Inquire...
Medicine Products: